Trial fails of ruxolitinib in COVID-19 complications- Novartis ...Middle East

Novartis said a late-stage clinical trial of ruxolitinib on top of standard therapy showed no significant reduction in severe complications of COVID-19, including death, respiratory failure requiring mechanical ventilation or admission to the intensive care unit.

Hence then, the article about trial fails of ruxolitinib in covid 19 complications novartis was published today ( Monday 14/12/2020 - 10:30 AM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Trial fails of ruxolitinib in COVID-19 complications- Novartis )

Also on site :

• Voices: An Andy Burnham coronation is not the answer to Labour’s problems
• Trump’s bargain with Iran: Letters to the Editor — June 20, 2026
• With Strait of Hormuz held hostage, Trump’s Iran deal is worse than Obama’s